Advertisement
Advertisement

PAVM

PAVM logo

PAVmed Inc

0.61
USD
-0.07
-10.29%
Dec 18, 14:36 UTC -5
Closed
...

PAVmed Inc Profile

About

PAVmed Inc. is a medical device company. Its diversified pipeline of products address unmet clinical needs, which consists of CarpX (TM) to treat carpal tunnel syndrome; NextFlo(TM) and NextCath(TM) a disposable infusion pump; PortIO(TM) and NextCath interventional radiology and Caldus (TM) tissue ablation and cardiovascular intervention. PAVmed Inc. is headquartered in New York City.

Info & Links

CEO

Lishan Aklog

Headquarters

360 MADISON AVENUE, 25TH FLOOR
NEW YORK, NY 10017, UNITED STATES

Auditor

Marcum LLP

Share holders

225

Employees

107

PAVmed Inc Statistics

Valuation Measures

Market Capitalization2

6.75M

Enterprise Value

38.04M

Enterprise Value/EBITDA(ttm)

-0.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.10

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-58.75%

Operating Margin(ttm)

-803.22%

Profit Margin(ttm)

392.70%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-404.31%

Return on Assets(ttm)

-92.36%

Income Statement

Revenue(ttm)

4.03M

Revenue Per Share(ttm)

0.36

Gross Profit(ttm)

-2.37M

EBITDA(ttm)3

-53.83M

Net Income Available to Common(ttm)

14.72M

Diluted EPS(ttm)

-4.35

Share Statistics

Beta (5Y Monthly)

0.67

52-Week Change

-84.78%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

11.07M

Dividend Yield

0.00%

Float4

9.82M

% Held by Insiders

11.30%

% Held by Institutions

19.93%

Balance Sheet

Total Cash(mrq)

765.00K

Total Cash Per Share(mrq)

0.07

Total Debt(mrq)

32.05M

Total Debt/Equity(mrq)

-341.43%

Current Ratio(mrq)

0.06%

Quick Ratio(mrq)

0.06%

Book Value Per Share(mrq)

-0.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.76

Free Cash Flow(ytd)

-33.70M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement